News
Moderna Inc. (NASDAQ:MRNA) is one of the best mid cap growth stocks to invest in now. On June 12, the US FDA expanded the ...
Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
But one of the standout moments during the hearing occurred when Kennedy suggested that a sitting member of Congress only ...
Nektar Therapeutics said its embattled immune drug rezpeg significantly improved skin clearance rates in patients with atopic ...
Makary and Center for Biologics Evaluation and Research Director Vinay Prasad unveiled a new framework in the New England ...
On Wednesday, the eight new members of the CDC’s Advisory Committee on Immunization Practices will begin a 2-day meeting in ...
A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...
Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
Novo Nordisk is halting its collaboration with Hims & Hers Health over the sale of weight loss drugs, STAT says. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback